The U.S. Food and Medication Administration authorised CTI BioPharma Corp's drug for treating adult patients with a kind of bone...
Read moreLast year, GlaxoSmithKline’s ViiV Healthcare’s feat of getting a long-awaited approval of HIV treatment by the name of Cabenuva was...
Read moreAptar Pharma, a global leader in drug delivery systems, services and active material science solutions, announced that its VP3 multidose...
Read moreGilead Sciences, Inc. announced that the U.S. FDA has granted expedited approval of a supplemental new drug application (sNDA) for...
Read moreNovavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Australia's Therapeutic...
Read moreMerck, known as MSD outside the United States and Canada, announced that the EC has approved KEYTRUDA, Merck’s anti-PD-1 therapy,...
Read moreThere is currently no cure for cystic fibrosis (CF), a debilitating, progressive condition with over 10,830 people in the UK...
Read moreA new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely...
Read morePfizer Inc. and BioNTech SE announced that the U.S. FDA has expanded the EUA of a booster dose of the...
Read moreWuXi AppTec’s WuXi STA has said that its facility at Waigaoqiao near Shanghai has cleared its first FDA drug product...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.